EUVIMEDEUVIMED entdecken
Crossref

Lanthanide-doped nanoparticles: An emerging platform for theranostic applications in neurodegenerative diseases

Jialin Liu, Lihua Li

BME Horizon · 2026

DOI: 10.70401/bmeh.2026.0030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BME Horizon, 2026. Verfasst von Jialin Liu und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lanthanide-doped nanoparticles (LNPs) offer an emerging non-invasive theranostic platform for monitoring and treating neurodegenerative diseases (NDs) own to their high optical stability, deep tissue penetration, and excellent biocompatibility. Their key advantage lies in the ability to produce upconversion or downshifting luminescence under near-infrared excitation, enabling high-resolution deep-tissue imaging and in situ monitoring, particularly suitable for tracking pathological progression and studying molecular interactions in disorders such as Alzheimer’s disease and Parkinson’s disease. By integrating functional components such as organic dyes, noble metal nanoparticles, or therapeutic agents, LNPs can be engineered into multifunctional theranostic nanoplatforms capable of simultaneous diagnosis and targeted therapy. Moreover, their precisely tunable emission properties open new avenues for deep-brain imaging and optical modulation. This review systematically summarizes the luminescence mechanisms of LNPs and recent advances in their applications for biosensing and diagnosis in NDs. It covers the detection of key biomarkers, including metal ions, nucleic acids, proteins, and reactive oxygen species. The discussion further extends to the therapeutic strategies targeting intracellular and microenvironmental factors, as well as synergistic approaches, with a particular emphasis on the role of LNPs in targeted drug delivery and combined theranostics. Finally, the review discusses future prospects for leveraging this platform to improve clinical outcomes in NDs.

Zitieren

APA

Liu, J., & Li, L. (2026). Lanthanide-doped nanoparticles: An emerging platform for theranostic applications in neurodegenerative diseases. BME Horizon. https://doi.org/10.70401/bmeh.2026.0030

Vancouver

Liu J, Li L. Lanthanide-doped nanoparticles: An emerging platform for theranostic applications in neurodegenerative diseases. BME Horizon. 2026. doi:10.70401/bmeh.2026.0030

BibTeX
@article{Liu2026,
  author = {Liu, Jialin and Li, Lihua},
  title = {Lanthanide-doped nanoparticles: An emerging platform for theranostic applications in neurodegenerative diseases},
  journal = {BME Horizon},
  year = {2026},
  doi = {10.70401/bmeh.2026.0030}
}
Kostenlos starten →